Literature DB >> 9179153

The role of leukemia inhibitory factor in skeletal muscle regeneration.

J B Kurek1, J J Bower, M Romanella, F Koentgen, M Murphy, L Austin.   

Abstract

Although a number of cytokines have been implicated in tissue regeneration, it is unknown which ones actually function in vivo. Here, we use mice with a targeted mutation in the leukemia inhibitory factor (LIF) gene to examine the role of LIF in muscle regeneration. Using a muscle crush model, we show that muscle regeneration in LIF knockout mice is significantly, reduced compared to control littermates. Further, targeted infusion of LIF in both normal and LIF knockout animals stimulated muscle regeneration, but the stimulation observed was much greater in the mutant animals than in controls. In contrast, interleukin-6 and transforming growth factor-alpha, which also stimulate myoblast proliferation in vitro, had no effect on regeneration. These findings demonstrate directly that LIF is involved in regeneration of injured muscle and points to the use of LIF as a therapeutic agent in the treatment of neuromuscular disease.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9179153     DOI: 10.1002/(sici)1097-4598(199707)20:7<815::aid-mus5>3.0.co;2-a

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  39 in total

Review 1.  Peripheral nerve regeneration and neurotrophic factors.

Authors:  G Terenghi
Journal:  J Anat       Date:  1999-01       Impact factor: 2.610

2.  Regulation of neurokine receptor signaling and trafficking.

Authors:  Neil M Nathanson
Journal:  Neurochem Int       Date:  2012-01-25       Impact factor: 3.921

3.  Physiology of Mechanotransduction: How Do Muscle and Bone "Talk" to One Another?

Authors:  Janalee Isaacson; Marco Brotto
Journal:  Clin Rev Bone Miner Metab       Date:  2014-06

Review 4.  Leukemia inhibitory factor (LIF).

Authors:  Nicos A Nicola; Jeffrey J Babon
Journal:  Cytokine Growth Factor Rev       Date:  2015-07-04       Impact factor: 7.638

5.  Intracellular and extracellular leukemia inhibitory factor proteins have different cellular activities that are mediated by distinct protein motifs.

Authors:  B P Haines; R B Voyle; P D Rathjen
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

6.  Genetic reduction of embryonic leukemia-inhibitory factor production rescues placentation in SOCS3-null embryos but does not prevent inflammatory disease.

Authors:  Lorraine Robb; Kristy Boyle; Steven Rakar; Lynne Hartley; Janelle Lochland; Andrew W Roberts; Warren S Alexander; Donald Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-28       Impact factor: 11.205

7.  Regeneration of transgenic skeletal muscles with altered timing of expression of the basic helix-loop-helix muscle regulatory factor MRF4.

Authors:  Grace K Pavlath; Janice A Dominov; Kristy M Kegley; Jeffrey Boone Miller
Journal:  Am J Pathol       Date:  2003-05       Impact factor: 4.307

8.  Reciprocal regulation of ciliary neurotrophic factor receptors and acetylcholine receptors during synaptogenesis in embryonic chick atria.

Authors:  X Wang; S W Halvorsen
Journal:  J Neurosci       Date:  1998-09-15       Impact factor: 6.167

9.  Acute resistance exercise increases the expression of chemotactic factors within skeletal muscle.

Authors:  Paul A Della Gatta; David Cameron-Smith; Jonathan M Peake
Journal:  Eur J Appl Physiol       Date:  2014-06-27       Impact factor: 3.078

10.  Interleukin-6-induced satellite cell proliferation is regulated by induction of the JAK2/STAT3 signalling pathway through cyclin D1 targeting.

Authors:  M Kurosaka; S Machida
Journal:  Cell Prolif       Date:  2013-08       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.